Diagnostic cut‐off of Aspergillus fumigatus‐specific IgG in the diagnosis of chronic pulmonary aspergillosis

Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for A. fumigatus‐specific IgG remains unknown. We included consecutive treatment‐naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The...

Full description

Saved in:
Bibliographic Details
Published inMycoses Vol. 61; no. 10; pp. 770 - 776
Main Authors Sehgal, Inderpaul Singh, Choudhary, Hansraj, Dhooria, Sahajal, Aggarwal, Ashutosh Nath, Garg, Mandeep, Chakrabarti, Arunaloke, Agarwal, Ritesh
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for A. fumigatus‐specific IgG remains unknown. We included consecutive treatment‐naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut‐off of A. fumigatus‐specific IgG (Phadia), subjects were randomly classified as derivation (two‐thirds) and validation (one‐third) cohort. One hundred and thirty‐seven cases and 50 controls were included. The best cut‐off value for A. fumigatus‐specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut‐off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut‐off value of 27 mgA/L, A. fumigatus‐specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings.
AbstractList Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A. fumigatus-specific IgG remains unknown. We included consecutive treatment-naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut-off of A. fumigatus-specific IgG (Phadia), subjects were randomly classified as derivation (two-thirds) and validation (one-third) cohort. One hundred and thirty-seven cases and 50 controls were included. The best cut-off value for A. fumigatus-specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut-off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut-off value of 27 mgA/L, A. fumigatus-specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings.
Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A. fumigatus-specific IgG remains unknown. We included consecutive treatment-naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut-off of A. fumigatus-specific IgG (Phadia), subjects were randomly classified as derivation (two-thirds) and validation (one-third) cohort. One hundred and thirty-seven cases and 50 controls were included. The best cut-off value for A. fumigatus-specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut-off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut-off value of 27 mgA/L, A. fumigatus-specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings.Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A. fumigatus-specific IgG remains unknown. We included consecutive treatment-naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut-off of A. fumigatus-specific IgG (Phadia), subjects were randomly classified as derivation (two-thirds) and validation (one-third) cohort. One hundred and thirty-seven cases and 50 controls were included. The best cut-off value for A. fumigatus-specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut-off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut-off value of 27 mgA/L, A. fumigatus-specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings.
Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for A. fumigatus‐specific IgG remains unknown. We included consecutive treatment‐naïve subjects with chronic cavitary pulmonary aspergillosis (CCPA, cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [BALF] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut‐off of A. fumigatus‐specific IgG (Phadia), subjects were randomly classified as derivation (two‐thirds) and validation (one‐third) cohort. One hundred and thirty‐seven cases and 50 controls were included. The best cut‐off value for A. fumigatus‐specific IgG (derivation cohort) was 27.3 mgA/L (AUROC, 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut‐off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut‐off value of 27 mgA/L, A. fumigatus‐specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA. More studies are required to confirm our findings.
Aspergillus fumigatus ‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis ( CPA ). However, the cut‐off value for A. fumigatus ‐specific IgG remains unknown. We included consecutive treatment‐naïve subjects with chronic cavitary pulmonary aspergillosis ( CCPA , cases). The controls were subjects with treated pulmonary tuberculosis, who had residual radiological abnormality and minimal symptoms. The diagnosis of CCPA was based on consistent clinicoradiological features along with demonstration of Aspergillus infection (growth of Aspergillus in sputum or bronchoalveolar lavage fluid [ BALF ] culture; serum or BALF galactomannan index >0.5 and >1, respectively). For determining the cut‐off of A. fumigatus ‐specific IgG (Phadia), subjects were randomly classified as derivation (two‐thirds) and validation (one‐third) cohort. One hundred and thirty‐seven cases and 50 controls were included. The best cut‐off value for A. fumigatus ‐specific IgG (derivation cohort) was 27.3 mgA/L ( AUROC , 0.976) at a sensitivity and specificity of 95.6% and 100%, respectively. Using a cut‐off of 27 mgA/L, the sensitivity and specificity in the validation cohort was 91.3% and 100%, respectively. In contrast, the sensitivity of Aspergillus precipitins was only 25.5%. At a cut‐off value of 27 mgA/L, A. fumigatus ‐specific IgG is a reliable test with high sensitivity and specificity in the diagnosis of CPA . More studies are required to confirm our findings.
Author Dhooria, Sahajal
Aggarwal, Ashutosh Nath
Chakrabarti, Arunaloke
Choudhary, Hansraj
Garg, Mandeep
Agarwal, Ritesh
Sehgal, Inderpaul Singh
Author_xml – sequence: 1
  givenname: Inderpaul Singh
  orcidid: 0000-0002-6505-6019
  surname: Sehgal
  fullname: Sehgal, Inderpaul Singh
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 2
  givenname: Hansraj
  surname: Choudhary
  fullname: Choudhary, Hansraj
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 3
  givenname: Sahajal
  surname: Dhooria
  fullname: Dhooria, Sahajal
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 4
  givenname: Ashutosh Nath
  surname: Aggarwal
  fullname: Aggarwal, Ashutosh Nath
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 5
  givenname: Mandeep
  surname: Garg
  fullname: Garg, Mandeep
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 6
  givenname: Arunaloke
  surname: Chakrabarti
  fullname: Chakrabarti, Arunaloke
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
– sequence: 7
  givenname: Ritesh
  orcidid: 0000-0003-2547-7668
  surname: Agarwal
  fullname: Agarwal, Ritesh
  email: agarwal.ritesh@outlook.in
  organization: Postgraduate Institute of Medical Education and Research (PGIMER)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29920796$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1OGzEUha0KVELaRV-gGqmbshjwT2zHS5RCiARiQxddWY7HThzN2FN7LJQdj8Az8iQ4BFggtd5Y8v3O0fU5x-DAB28A-IbgKSrnrNvqU4SniH4CIzQhooYU8gMwgoKQmk8gPwLHKW0gRFxg9hkcYSEw5IKNQP_LqZUPaXC60nl4engM1lbBVuepN3Hl2janyubOrdSQUxmXZ-1soRereeV8NaxN1ew9XNoJ9ToGX-Z9brvgVdxW6s1qh3wBh1a1yXx9vcfg9-XF3eyqvr6dL2bn17UmlNBaKYYgJUveIAYbWNY1y4YxoqklmE2V4EskMILcWmEwoVPImSDICMMaKpghY_Bz79vH8DebNMjOJW3aVnkTcpIYUj6ZYF4iGoMfH9BNyNGX7SQu8UJGSFllDL6_UnnZmUb20XXld_ItywKc7AEdQ0rR2HcEQbnrSZae5EtPhT37wGo3qMEFP0Tl2v8p7l1rtv-2ljd_ZnvFM5iApUA
CitedBy_id crossref_primary_10_1128_JCM_02018_21
crossref_primary_10_3390_jof6020075
crossref_primary_10_1097_MCP_0000000000001026
crossref_primary_10_1007_s11046_023_00756_8
crossref_primary_10_1007_s11046_023_00751_z
crossref_primary_10_1371_journal_pone_0222738
crossref_primary_10_1371_journal_ppat_1008742
crossref_primary_10_1111_myc_13747
crossref_primary_10_1111_myc_13229
crossref_primary_10_1111_myc_13746
crossref_primary_10_3390_jof6040202
crossref_primary_10_3390_jof6040249
crossref_primary_10_1016_S1473_3099_22_00057_3
crossref_primary_10_1021_jacsau_1c00318
crossref_primary_10_1016_j_mycmed_2019_100898
crossref_primary_10_1111_myc_12987
crossref_primary_10_1016_j_ijregi_2022_11_005
crossref_primary_10_1111_myc_13711
crossref_primary_10_2147_IDR_S479714
crossref_primary_10_1016_j_rmed_2020_106290
crossref_primary_10_1016_j_cmi_2019_12_009
crossref_primary_10_1111_myc_13553
crossref_primary_10_1016_j_mycmed_2020_100932
crossref_primary_10_1128_JCM_00538_19
crossref_primary_10_1080_17476348_2020_1750956
crossref_primary_10_3389_fmicb_2022_1060727
crossref_primary_10_1128_JCM_01821_18
crossref_primary_10_1177_20499361211050158
crossref_primary_10_4103_ijrc_ijrc_98_20
crossref_primary_10_1055_s_0043_1776913
crossref_primary_10_1016_j_cmi_2019_01_007
crossref_primary_10_3390_jof7060480
crossref_primary_10_1016_j_jaip_2018_08_034
crossref_primary_10_1093_mmy_myac063
crossref_primary_10_1111_myc_13253
crossref_primary_10_4269_ajtmh_22_0366
crossref_primary_10_1016_j_cmi_2022_11_031
crossref_primary_10_1016_j_mimet_2020_106021
crossref_primary_10_3390_jof8020110
crossref_primary_10_1186_s12890_020_1125_y
crossref_primary_10_3390_jof8040400
crossref_primary_10_1016_j_ijmmb_2022_03_002
crossref_primary_10_1097_MCP_0000000000000940
crossref_primary_10_1093_infdis_jiae409
crossref_primary_10_20862_0042_4676_2021_102_5_317_328
crossref_primary_10_1097_MOP_0000000000000898
crossref_primary_10_1007_s11046_024_00917_3
crossref_primary_10_1111_myc_13730
crossref_primary_10_1111_myc_13143
crossref_primary_10_1111_myc_13583
crossref_primary_10_3389_fcimb_2020_602836
crossref_primary_10_1016_j_heliyon_2023_e15356
crossref_primary_10_1177_20499361241253751
crossref_primary_10_7759_cureus_16418
Cites_doi 10.1093/cid/ciw444
10.1111/myc.12541
10.1371/journal.pone.0114745
10.1111/j.1749-6632.1974.tb28200.x
10.1016/j.diagmicrobio.2018.01.001
10.1016/j.cmi.2018.01.002
10.1086/376526
10.1016/j.jinf.2014.01.005
10.1016/j.alit.2018.04.009
10.2471/BLT.11.089441
10.1016/j.jinf.2015.11.003
10.1111/myc.12075
10.1093/mmy/myy012
10.1373/clinchem.2006.067546
10.1093/cid/ciw326
10.3109/13693786.2012.682228
10.1111/1469-0691.12133
10.1111/j.1440-1843.2009.01548.x
10.1183/13993003.00583-2015
10.7150/ijbs.5459
10.1093/mmy/myy024
ContentType Journal Article
Copyright 2018 Blackwell Verlag GmbH
2018 Blackwell Verlag GmbH.
Copyright_xml – notice: 2018 Blackwell Verlag GmbH
– notice: 2018 Blackwell Verlag GmbH.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
M7N
7X8
DOI 10.1111/myc.12815
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Algology Mycology and Protozoology Abstracts (Microbiology C)
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1439-0507
EndPage 776
ExternalDocumentID 29920796
10_1111_myc_12815
MYC12815
Genre article
Evaluation Studies
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1OB
1OC
29M
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
M7N
7X8
ID FETCH-LOGICAL-c3535-aa61053b7d160d0920ebd663c5f3268a97b192107ff9e2358076931e9e6d596e3
IEDL.DBID DR2
ISSN 0933-7407
1439-0507
IngestDate Fri Jul 11 04:31:10 EDT 2025
Fri Jul 25 07:07:34 EDT 2025
Thu Apr 03 07:08:24 EDT 2025
Tue Jul 01 04:30:59 EDT 2025
Thu Apr 24 22:53:09 EDT 2025
Wed Jan 22 16:20:48 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords IgG
chronic pulmonary aspergillosis
ImmunoCap
aspergillosis
ELISA
Language English
License 2018 Blackwell Verlag GmbH.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3535-aa61053b7d160d0920ebd663c5f3268a97b192107ff9e2358076931e9e6d596e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0002-6505-6019
0000-0003-2547-7668
PMID 29920796
PQID 2111063305
PQPubID 2045122
PageCount 7
ParticipantIDs proquest_miscellaneous_2057442793
proquest_journals_2111063305
pubmed_primary_29920796
crossref_primary_10_1111_myc_12815
crossref_citationtrail_10_1111_myc_12815
wiley_primary_10_1111_myc_12815_MYC12815
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2018
2018-10-00
2018-Oct
20181001
PublicationDateYYYYMMDD 2018-10-01
PublicationDate_xml – month: 10
  year: 2018
  text: October 2018
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Berlin
PublicationTitle Mycoses
PublicationTitleAlternate Mycoses
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2013; 19
2012; 50
2009; 14
2006; 52
2017; 60
2013; 56
2018; 91
2016; 63
2003; 37
2018
2014; 68
2016; 72
2011; 89
2014; 9
1974; 221
2016; 47
2012; 8
2018; 24
e_1_2_5_15_1
e_1_2_5_14_1
e_1_2_5_17_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_8_1
e_1_2_5_11_1
e_1_2_5_7_1
e_1_2_5_10_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_21_1
e_1_2_5_5_1
e_1_2_5_12_1
e_1_2_5_22_1
e_1_2_5_4_1
e_1_2_5_3_1
e_1_2_5_2_1
e_1_2_5_19_1
e_1_2_5_18_1
e_1_2_5_20_1
References_xml – volume: 24
  start-page: e1
  year: 2018
  end-page: e38
  article-title: Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID‐ECMM‐ERS guideline
  publication-title: Clin Microbiol Infect
– volume: 47
  start-page: 45
  year: 2016
  end-page: 68
  article-title: Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
  publication-title: Eur Respir J
– volume: 63
  start-page: e1
  year: 2016
  end-page: e60
  article-title: Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America
  publication-title: Clin Infect Dis
– volume: 37
  start-page: S265
  issue: Suppl 3
  year: 2003
  end-page: S280
  article-title: Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review
  publication-title: Clin Infect Dis
– volume: 50
  start-page: 811
  year: 2012
  end-page: 817
  article-title: Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis
  publication-title: Med Mycol
– volume: 72
  start-page: 240
  year: 2016
  end-page: 249
  article-title: Comparison of six Aspergillus‐specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)
  publication-title: J Infect
– year: 2018
  article-title: Concordance between Aspergillus‐specific precipitating antibody and IgG in allergic bronchopulmonary aspergillosis
  publication-title: Allergol Int
– year: 2018
  article-title: Prevalence of sensitization to in patients with allergic bronchopulmonary aspergillosis
  publication-title: Med Mycol
– volume: 19
  start-page: E197
  year: 2013
  end-page: E204
  article-title: Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis
  publication-title: Clin Microbiol Infect
– volume: 14
  start-page: 701
  year: 2009
  end-page: 708
  article-title: Comparison of Aspergillus galactomannan antigen testing with a new cut‐off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis
  publication-title: Respirology
– volume: 91
  start-page: 47
  issue: 1
  year: 2018
  end-page: 51
  article-title: Receiver operating characteristic curve analysis of four Aspergillus‐specific IgG assays for the diagnosis of chronic pulmonary aspergillosis
  publication-title: Diagn Microbiol Infect Dis
– volume: 52
  start-page: 1785
  year: 2006
  end-page: 1793
  article-title: Quantification of IgG antibodies to and pigeon antigens by ImmunoCAP technology: an alternative to the precipitation technique?
  publication-title: Clin Chem
– volume: 221
  start-page: 64
  year: 1974
  end-page: 75
  article-title: Measurement of humoral antibodies to aspergilli
  publication-title: Ann N Y Acad Sci
– volume: 8
  start-page: 1418
  year: 2012
  end-page: 1419
  article-title: Consideration in selection of the control group in diagnostic tests
  publication-title: Int J Biol Sci
– volume: 60
  start-page: 33
  year: 2017
  end-page: 39
  article-title: Role of ‐specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis
  publication-title: Mycoses
– volume: 68
  start-page: 494
  year: 2014
  end-page: 499
  article-title: Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis
  publication-title: J Infect
– volume: 56
  start-page: 559
  year: 2013
  end-page: 570
  article-title: Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature
  publication-title: Mycoses
– year: 2018
  article-title: Siemens immulite Aspergillus‐specific IgG assay for chronic pulmonary aspergillosis diagnosis
  publication-title: Med Mycol
– volume: 89
  start-page: 864
  year: 2011
  end-page: 872
  article-title: Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis
  publication-title: Bull World Health Organ
– volume: 9
  start-page: e114745
  year: 2014
  article-title: Estimation of the burden of chronic and allergic pulmonary aspergillosis in India
  publication-title: PLoS ONE
– volume: 63
  start-page: 433
  year: 2016
  end-page: 442
  article-title: Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America
  publication-title: Clin Infect Dis
– ident: e_1_2_5_15_1
  doi: 10.1093/cid/ciw444
– ident: e_1_2_5_22_1
  doi: 10.1111/myc.12541
– ident: e_1_2_5_7_1
  doi: 10.1371/journal.pone.0114745
– ident: e_1_2_5_19_1
  doi: 10.1111/j.1749-6632.1974.tb28200.x
– ident: e_1_2_5_8_1
  doi: 10.1016/j.diagmicrobio.2018.01.001
– ident: e_1_2_5_2_1
  doi: 10.1016/j.cmi.2018.01.002
– ident: e_1_2_5_5_1
  doi: 10.1086/376526
– ident: e_1_2_5_17_1
  doi: 10.1016/j.jinf.2014.01.005
– ident: e_1_2_5_20_1
  doi: 10.1016/j.alit.2018.04.009
– ident: e_1_2_5_6_1
  doi: 10.2471/BLT.11.089441
– ident: e_1_2_5_9_1
  doi: 10.1016/j.jinf.2015.11.003
– ident: e_1_2_5_14_1
  doi: 10.1111/myc.12075
– ident: e_1_2_5_21_1
  doi: 10.1093/mmy/myy012
– ident: e_1_2_5_11_1
  doi: 10.1373/clinchem.2006.067546
– ident: e_1_2_5_3_1
  doi: 10.1093/cid/ciw326
– ident: e_1_2_5_18_1
  doi: 10.3109/13693786.2012.682228
– ident: e_1_2_5_10_1
  doi: 10.1111/1469-0691.12133
– ident: e_1_2_5_16_1
  doi: 10.1111/j.1440-1843.2009.01548.x
– ident: e_1_2_5_4_1
  doi: 10.1183/13993003.00583-2015
– ident: e_1_2_5_12_1
  doi: 10.7150/ijbs.5459
– ident: e_1_2_5_13_1
  doi: 10.1093/mmy/myy024
SSID ssj0017926
Score 2.4378495
Snippet Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for...
Aspergillus fumigatus ‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis ( CPA ). However, the cut‐off value for A. fumigatus...
Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for...
Aspergillus fumigatus‐specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut‐off value for A....
Aspergillus fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A....
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 770
SubjectTerms Adult
Aged
Alveoli
Antibodies, Fungal - blood
Aspergillosis
Aspergillus
Aspergillus fumigatus
Aspergillus fumigatus - immunology
Aspergillus fumigatus - isolation & purification
Bronchus
Chronic Disease
chronic pulmonary aspergillosis
Diagnosis
ELISA
Female
Humans
IgG
ImmunoCap
Immunoglobulin G
Immunoglobulin G - blood
Male
Mannans - analysis
Middle Aged
Municipalities
Precipitins
Prospective Studies
Pulmonary Aspergillosis - diagnosis
Pulmonary Aspergillosis - diagnostic imaging
Pulmonary Aspergillosis - microbiology
Radiography, Thoracic
ROC Curve
Sensitivity and Specificity
Sputum
Tuberculosis
Yard waste
Title Diagnostic cut‐off of Aspergillus fumigatus‐specific IgG in the diagnosis of chronic pulmonary aspergillosis
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fmyc.12815
https://www.ncbi.nlm.nih.gov/pubmed/29920796
https://www.proquest.com/docview/2111063305
https://www.proquest.com/docview/2057442793
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB4hEBIX3o_yqAziwCVV0sRJI07l0WWRygGBBBJS5Dh2VVHSijQHOPET-I37S3YmTiLYXaQVt0geO449Y38Tj78BOHSEo7noOBaXXFmep11L4E5hha4MuKNtXxepE_pX_sWtd3nH72bguLoLY_gh6h9uZBnFek0GLuLsg5E_vcgWHQPRBXOK1SJAdF1TR6GeFanWyGG3AvRaSlYhiuKpa37ei_4CmJ_xarHh9JbgoeqqiTN5bOXTuCVf_2Bx_Oa3LMNiCURZ12jOCsyodBXmTWrKlzWYnJkYPCxlMp_-ensfa83GmnWJWnwwHI3yjOn8iRg68gyL6comhR2xn4MfbJgyBJYsMW0MM6ooDQ0vm-QjVH3sKxNVUySyDre985vTC6vMzmBJl7vcEgKRF3fjIHF8O7HDtq3iBPGL5BohYUeEQUxca3agdajoQq5NaRcdFSo_4aGv3A2YTcep2gKWBB2tHCHa6I97vo4RtAqEPopjE67sJA04quYpkiV1OWXQGEWVC4MDGBUD2ICDWnRi-Dr-JbRbTXZUmmwWoSeM7rGL618D9utiNDY6QRGpGucog-jW89q4pjVg0yhJ_Rbc19t2EPrY2WKqv3591L8_LR62_190BxYQqhkmXmcXZqfPudpDODSNmzDXPTk76TUL_f8NeRgIvA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB7xEGIvy2MXKE-DOHBJlTRx0khcEK_yKAcEEhxWkePYVbUlrWhzYE_8BH4jv4SZOImABQlxi-TxI_aM_Y0f3wBsO8LRXDQdi0uuLM_TriVwpbBCVwbc0bav89AJ7Qu_de2d3vCbMdgt38IYfohqw40sI5-vycBpQ_qVld89yDqdA_FxmKSI3sScf3BZkUehpuXB1shltwL0WwpeIbrHU2V9uxr9BzHfItZ8yTmagT9lY81Nk7_1bBTX5b93PI7f_ZtZ-FlgUbZnlGcOxlQ6D1MmOuXDLxgcmGt4mMpkNnp-fOprzfqa7RG7eKfb62VDprM7IunIhphMrzbp5hE76RyzbsoQW7LElNEdUkZpmHjZIOuh9mNjmSiLIpHfcH10eLXfsooADZZ0ucstIRB8cTcOEse3Ezts2CpOEMJIrhEVNkUYxES3Zgdah4re5NoUedFRofITHvrKXYCJtJ-qJWBJ0NTKEaKBLrnn6xhxq0D0ozgW4cpmUoOdcqAiWbCXUxCNXlR6MdiBUd6BNdiqRAeGsuMjodVytKPCaocROsPoIbs4BdZgs0pGe6NDFJGqfoYyCHA9r4HTWg0WjZZUteDS3rCD0MfG5mP9efVR-3Y__1j-uugGTLeu2ufR-cnF2Qr8QORmiHmdVZgY3WdqDdHRKF7PjeAFm3ELZg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-VTkO88LEx6Chgpj3wkipfThrtqWopG9BqQkwaElLkOHZV0aYVbR66p_0J-xv3l3AXJ9E-QEK8RfLZcew7-3fx-XcAh45wNBddx-KSK8v3tWcJ3CmsyJMhd7Qd6CJ1wmgcHJ_5n875eQOOqrswhh-i_uFGllGs12Tgy1TfMPL5RnboGIg_gC0_sCPK2zD4WnNHoaIVudbIY7dCdFtKWiEK46mr3t6M7iHM24C12HGGT-BH1VcTaPKzk6-Tjry4Q-P4nx_zFB6XSJT1jOo8g4bKdmDb5Kbc7MJyYILwsJTJfH19ebXQmi006xG3-GQ6m-UrpvM5UXTkKyymO5sUd8ROJh_ZNGOILFlq2piuqKI0PLxsmc9Q97GvTFRNkchzOBt--NY_tsr0DJb0uMctIRB6cS8JUyewUztybZWkCGAk14gJuyIKEyJbs0OtI0U3cm3Ku-ioSAUpjwLl7UEzW2TqJbA07GrlCOGiQ-4HOkHUKhD7KI5NeLKbtuB9NU-xLLnLKYXGLK58GBzAuBjAFhzUoktD2PEnoXY12XFps6sYXWH0jz1cAFvwri5Ga6MjFJGpRY4yCG9938VFrQUvjJLUb8GN3bXDKMDOFlP999fHo-_94mH_30XfwsPTwTD-cjL-_AoeIWwzrLxOG5rrX7l6jdBonbwpTOA3egsKFQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+cut-off+of+Aspergillus+fumigatus-specific+IgG+in+the+diagnosis+of+chronic+pulmonary+aspergillosis&rft.jtitle=Mycoses&rft.au=Sehgal%2C+Inderpaul+Singh&rft.au=Choudhary%2C+Hansraj&rft.au=Dhooria%2C+Sahajal&rft.au=Aggarwal%2C+Ashutosh+Nath&rft.date=2018-10-01&rft.eissn=1439-0507&rft.volume=61&rft.issue=10&rft.spage=770&rft_id=info:doi/10.1111%2Fmyc.12815&rft_id=info%3Apmid%2F29920796&rft.externalDocID=29920796
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0933-7407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0933-7407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0933-7407&client=summon